Cited by 273Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisEffects of Radiation ExposureTGF-β signaling in diseases

Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis

Open access
Puthawala, Khalid, Hadjiangelis, Nicos, Jacoby, Steven C., Bayongan, Emmanuel, Zhao, Zhicheng, Yang, Zhiwei, Devitt, Mary Louise, Horan, Gerald S. +7 more·2008·American Journal of Respiratory and Critical Care Medicine

Abstract

Rationale: In experimental models, lung fibrosis is dependent on transforming growth factor (TGF)-β signaling. TGF-β is secreted in a latent complex with its propeptide, and TGF-β activators release TGF-β from this complex. Because the integrin αvβ6 is a major TGF-β activator in the lung, inhibition of αvβ6-mediated TGF-β activation is a logical strategy to treat lung fibrosis. Objectives: To determine, by genetic and pharmacologic approaches, whether murine radiation-induced lung fibrosis is dependent on αvβ6. Methods: Wild-type mice, αvβ6-deficient (Itgb6−/−) mice, and mice heterozygous for a Tgfb1 mutation that eliminates integrin-mediated activation (Tgfb1+/RGE) were exposed to 14 Gy thoracic radiation. Some mice were treated with an anti-αvβ6 monoclonal antibody or a soluble TGF-β receptor fusion protein. αvβ6 expression was determined by immunohistochemistry. Fibrosis, inflammation, and gene expression patterns were assessed 20–32 weeks postirradiation. Measurements and Main Results: β6 Integrin expression increased within the alveolar epithelium 18 weeks postirradiation, just before onset of fibrosis. Itgb6−/− mice were completely protected from fibrosis, but not from late radiation-induced mortality. Anti-αvβ6 therapy (1–10 mg/kg/wk) prevented fibrosis, but only higher doses (6–10 mg/kg/wk) caused lung inflammation similar to that in Itgb6−/− mice. Tgfb1-haploinsufficient mice were also protected from fibrosis. Conclusions: αvβ6-Mediated TGF-β activation is required for radiation-induced lung fibrosis. Together with previous data, our results demonstrate a robust requirement for αvβ6 in distinct fibrosis models. Inhibition of αvβ6-mediated TGF-β activation is a promising new approach for antifibrosis therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.200706-806oc

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-17A is a key inducer of fibrosis in several organ systems, including lung, liver, kidney, heart, and skin.

    “The pro-inflammatory cytokine IL-17A was identified as a key inducer of fibrosis in several different organ systems, including the lung, liver, kidney, heart, and skin109–114”

    From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [113]

  • A monoclonal antibody targeting integrin αVβ6 protects mice from radiation-induced fibrosis.

    “In addition, a monoclonal antibody targeting integrin αVβ6 has been shown to protect mice from radiation induced fibrosis (203).”

    From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [203]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Puthawala, K., Hadjiangelis, N., Jacoby, S. C., Bayongan, E., Zhao, Z., Yang, Z., Devitt, M. L., Horan, G. S., Weinreb, P. H., Lukashev, M. E., Violette, S. M., Grant, K. S., Colarossi, C., Formenti, S. C., & Munger, J. S.
Affiliations
  • York University (US)
  • Departments of Medicine
  • Cell Biology, and
  • New York University (US)
  • Biogen (United States) (US)
Corresponding author
Munger, John S.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2008-01-01
Volume
177
Issue
1
Pages
82-90
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2155139007
Cited by
272
References
45
Citations by year
2026: 7 · 2025: 11 · 2024: 13 · 2023: 12 · 2022: 15 · 2021: 15 · 2020: 14 · 2019: 7 · 2018: 16 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 30 · 2013: 16 · 2012: 18
FWCI
11.52
Type
journal article
Language
en
Open access
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Biogen
  • National Institutes of Health (5r01hl077526-04)
  • National Heart, Lung, and Blood Institute (HL063786, HL077526, R01HL063786)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
radiation-induced pulmonary fibrosis, TGF-beta activation, radiation-induced mortality, lung inflammation, antifibrotic therapy, alveolar epithelium
MeSH terms
Animals, Antibodies, Monoclonal, Antigens, Neoplasm, Disease Models, Animal, Dose-Response Relationship, Drug, Female, Gene Expression Regulation, Haplotypes, Heterozygote, Mice, Inbred C57BL, Pulmonary Alveoli, Pulmonary Fibrosis, Signal Transduction, Integrins, Transforming Growth Factor beta, Radiation Pneumonitis, Mice, Knockout, Mice, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review